Clinical Trials Directory

Trials / Completed

CompletedNCT00466011

Validation of the Stardust Cardio-Respiratory Recorder

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Associação Fundo de Incentivo à Pesquisa · Academic / Other
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Accepted

Summary

Introduction: The full night polysomnography (PSG) in sleep lab is the gold standard to Obstructive Sleep Apnea (OSA) diagnosis. However, there is a need to evaluate simple and accurate home diagnostic equipment that can reliably detect or exclude OSA. The aim of our study was to evaluate if an ambulatory portable monitor (SD) is accurate to measure apnea-hypopnea index (AHI) in OSA patients referred to a Sleep Lab. Methods: Patients with clinical suspicion of OSA were selected. Three-order randomized evaluations had been performed within a period of two weeks: the 1) SD (Stardust®, Respironics, Inc, USA) was used at patients home (SD home), 2) SD was used simultaneously with PSG in the sleep lab (SD+PSG lab) and 3) PSG was performed without the use of SD (PSG lab). Four AHI were generated and analyzed: AHI from SD home, AHI from SD of SD+PSG lab, AHI from PSG of PSG+SD lab and AHI from PSG lab. The analyses of SDs and PSGs recordings were performed by two blinded technicians.

Conditions

Timeline

Start date
2007-04-01
Primary completion
2007-11-01
Completion
2008-05-01
First posted
2007-04-27
Last updated
2012-07-12

Locations

2 sites across 1 country: Brazil

Source: ClinicalTrials.gov record NCT00466011. Inclusion in this directory is not an endorsement.